Severe Anemia Ups Necrotizing Enterocolitis Risk in VLBW

This article originally appeared here.
Share this content:
Severe Anemia Ups Necrotizing Enterocolitis Risk in VLBW
Severe Anemia Ups Necrotizing Enterocolitis Risk in VLBW

TUESDAY, March 1, 2016 (HealthDay News) -- Severe anemia, but not red blood cell (RBC) transfusion, is associated with increased risk of necrotizing enterocolitis (NEC) in very low-birth-weight (VLBW) infants, according to research published in the March 1 issue of the Journal of the American Medical Association.

Ravi M. Patel, M.D., of the Emory University School of Medicine in Atlanta, and colleagues evaluated data for 598 VLBW infants (≤1,500 g) enrolled in a secondary, prospective, multicenter observational cohort study. The association between RBC transfusion, severe anemia, and NEC was assessed.

The researchers found that 44 infants (7.4 percent) developed NEC, and 319 infants (53 percent) received RBC transfusions. In the unadjusted analysis, the cumulative incidence of NEC at week eight among RBC-transfused infants was 9.9 percent, compared to 4.6 percent among nontransfused infants. In multivariable analysis, RBC transfusion in a given week was not significantly associated with the rate of NEC (adjusted cause-specific hazard ratio, 0.44; 95 percent confidence interval, 0.17 to 1.12; P = 0.09). The rate of NEC among VLBW infants with severe anemia in a given week, compared with those who did not have severe anemia, was significantly increased (adjusted cause-specific hazard ratio, 5.99; 95 percent confidence interval, 2.00 to 18.0; P = 0.001).

"Among VLBW infants, severe anemia, but not RBC transfusion, was associated with an increased risk of NEC," the authors write. "Further studies are needed to evaluate whether preventing severe anemia is more important than minimizing RBC transfusion."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »